Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Mallinckrodt
Medtronic
Johnson and Johnson
Colorcon

Last Updated: December 9, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 207920

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

NDA 207920 describes NEXIUM 24HR, which is a drug marketed by Astrazeneca Lp and is included in two NDAs. It is available from two suppliers. There is one patent protecting this drug and one Paragraph IV challenge. Additional details are available on the NEXIUM 24HR profile page.

The generic ingredient in NEXIUM 24HR is esomeprazole magnesium. There are seventy-four drug master file entries for this compound. Ninety suppliers are listed for this compound. Additional details are available on the esomeprazole magnesium profile page.
Summary for 207920
Tradename:NEXIUM 24HR
Applicant:Astrazeneca Lp
Ingredient:esomeprazole magnesium
Patents:1
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 207920
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NEXIUM 24HR esomeprazole magnesium TABLET, DELAYED RELEASE;ORAL 207920 NDA Wyeth Consumer Healthcare LLC 0573-2451 0573-2451-14 1 BOTTLE in 1 CARTON (0573-2451-14) > 14 TABLET in 1 BOTTLE
NEXIUM 24HR esomeprazole magnesium TABLET, DELAYED RELEASE;ORAL 207920 NDA Wyeth Consumer Healthcare LLC 0573-2451 0573-2451-42 3 BOTTLE in 1 BLISTER PACK (0573-2451-42) > 14 TABLET in 1 BOTTLE
Paragraph IV (Patent) Challenges for 207920
Tradename Dosage Ingredient NDA Submissiondate
NEXIUM 24HR TABLET, DELAYED RELEASE;ORAL esomeprazole magnesium 207920 2016-09-09

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET, DELAYED RELEASE;ORALStrengthEQ 20MG BASE
Approval Date:Nov 23, 2015TE:RLD:Yes
Patent:  Start TrialPatent Expiration:May 3, 2020Product Flag?Substance Flag?Delist Request?Y

Expired US Patents for NDA 207920

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca Lp NEXIUM 24HR esomeprazole magnesium TABLET, DELAYED RELEASE;ORAL 207920-001 Nov 23, 2015   Start Trial   Start Trial
Astrazeneca Lp NEXIUM 24HR esomeprazole magnesium TABLET, DELAYED RELEASE;ORAL 207920-001 Nov 23, 2015   Start Trial   Start Trial
Astrazeneca Lp NEXIUM 24HR esomeprazole magnesium TABLET, DELAYED RELEASE;ORAL 207920-001 Nov 23, 2015   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Baxter
Mallinckrodt
Moodys
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.